Por favor, use este identificador para citar o enlazar este ítem:
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
- IOC - Artigos de Periódicos [12791]
Metadatos
Mostrar el registro completo del ítem
CHARACTERISTICS OF COVID-19 INFECTION IN A HOSPITALIZED AUTOIMMUNE HEPATITIS PATIENT
Autor
Afiliación
Resumen en ingles
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has become a major public health worldwide. Hepatic
dysfunction has been seen in patients with COVID-19 and could be related to a viral cytopathic effect,
an exacerbated immune reaction, or drug-induced liver damage. Currently, routine modification of
immunosuppressive therapy in patients with autoimmune hepatitis (AIH) before and after SARSCoV-
2 infection remains an important topic to be discussed. However, there is little evidence about
this thematic to support any recommendation. Here, we described a case report in which the use of
an immunosuppressive drug by a patient with diagnosed AIH might have influenced the COVID-19
clinical course with altered laboratory hematological and biochemical parameters during infection.
Compartir